This is a Validated Antibody Database (VAD) review about rat Ticam1, based on 7 published articles (read how Labome selects the articles), using Ticam1 antibody in all methods. It is aimed to help Labome visitors find the most suited Ticam1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ticam1 synonym: TIR domain-containing adapter molecule 1

Abcam
rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3a
In order to analyze the effects of dopamine related metabolite concentrations in M1 and M2 microglia phenotypes, Abcam Ticam1 antibody (Abcam, ab13810) was used in western blot on mouse samples at 1:1000 (fig 3a). Front Cell Neurosci (2017) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; 1:100; fig 5
  • western blot; rat; fig 6
Abcam Ticam1 antibody (Abcam, ab13810) was used in immunohistochemistry on rat samples at 1:100 (fig 5) and in western blot on rat samples (fig 6). BMC Cancer (2016) ncbi
rabbit polyclonal
  • western blot; rat
Abcam Ticam1 antibody (Abcam, ab13810) was used in western blot on rat samples . Int J Clin Exp Pathol (2015) ncbi
rabbit polyclonal
  • western blot; mouse; fig 1
Abcam Ticam1 antibody (Abcam, ab13810) was used in western blot on mouse samples (fig 1). Autophagy (2015) ncbi
rabbit polyclonal
  • western blot; rat; 1:1000
Abcam Ticam1 antibody (Abcam, ab13810) was used in western blot on rat samples at 1:1000. J Neurochem (2014) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
Abcam Ticam1 antibody (Abcam, ab13810) was used in western blot on human samples at 1:1000. Heart Vessels (2014) ncbi
Boster
goat polyclonal
  • western blot; human; 1:500; loading ...; fig 8c
Boster Ticam1 antibody (Boster, A01872) was used in western blot on human samples at 1:500 (fig 8c). Sci Transl Med (2017) ncbi
Articles Reviewed
  1. Zeng L, Kang R, Zhu S, Wang X, Cao L, Wang H, et al. ALK is a therapeutic target for lethal sepsis. Sci Transl Med. 2017;9: pubmed publisher
  2. Shan M, Lin S, Li S, Du Y, Zhao H, Hong H, et al. TIR-Domain-Containing Adapter-Inducing Interferon-? (TRIF) Is Essential for MPTP-Induced Dopaminergic Neuroprotection via Microglial Cell M1/M2 Modulation. Front Cell Neurosci. 2017;11:35 pubmed publisher
  3. Garcia P, Seiva F, Carniato A, de Mello Júnior W, Duran N, Macedo A, et al. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier. BMC Cancer. 2016;16:422 pubmed publisher
  4. Garcia P, Apolinário L, Böckelmann P, da Silva Nunes I, Duran N, Fávaro W. Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer. Int J Clin Exp Pathol. 2015;8:4427-43 pubmed
  5. Jabir M, Hopkins L, Ritchie N, Ullah I, Bayes H, Li D, et al. Mitochondrial damage contributes to Pseudomonas aeruginosa activation of the inflammasome and is downregulated by autophagy. Autophagy. 2015;11:166-82 pubmed publisher
  6. Jayakumar A, Tong X, Curtis K, Ruiz Cordero R, Abreu M, Norenberg M. Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy. J Neurochem. 2014;128:890-903 pubmed publisher
  7. Shao L, Zhang P, Zhang Y, Lu Q, Ma A. TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients. Heart Vessels. 2014;29:690-8 pubmed publisher